- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 193
Loadsmart plays clever for $19m
Freight services portal Loadsmart has now raised more than $53m in total, having secured new funding from investors including Ports America and Maersk Growth.
Sep 9, 2019Daily deal net: September 9, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 9, 2019Leyue Health lays out $16.1m series B
Chinese Academy of Sciences’ Investment Management unit put up a share of the proceeds for health insurance data analytics company Leyue Health’s series B round.
Sep 9, 2019Terramera takes $45m in series B round
The Ikea, Sumitomo and The Andersons-backed pest control product supplier has closed new funding, in a round led by Ospraie Ag Science.
Sep 9, 2019Corporate venturing deal net: 2-6 September 2019
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Sep 6, 2019Repare wraps up series B round
Celgene-backed Repare Therapeutics secured $82.5m that will support the entry of its first cancer drug into clinical trials.
Sep 6, 2019Neura lures corporates to $16m series B
The app engagement software developer raised the funding in a Liberty Technology Venture Capital-led round featuring Amdocs and existing investor Axa.
Sep 5, 2019Passage Bio packs in another $110m
University of Pennsylvania-allied CNS disease therapy developer Passage Bio lured contributions from investors including Lilly Asia Ventures, which also featured in its $116m series A earlier this year.
Sep 5, 2019Cartica AI clinches series B funding
Cartica AI, an autonomous perception tech developer forged from Technion spinout Cortica, secured capital from OurCrowd, Continental, Toyota and BMW in what appears to be its first publicly-disclosed round.
Sep 5, 2019Nkarta inks $114m series B deal
Nkarta, which is developing cell therapy treatments for cancer, has emerged from stealth with $114m in a round featuring Novo, Amgen Ventures and SR One.
Sep 5, 2019About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


